Skip to main content
Back to main menu

About Us

How we work

See what triggers an intervention and how supply and logistics allow our teams to respond quickly.

Learn more
How we're run

Discover our governance and what it means to be an association. Find a quick visual guide to our offices around the world.

Learn more
Reports and financials

Read through our annual financial and activity reports, and find out about where our funds come from and how they are spent.

Learn more
Accountability

Read the policies, reports, and plans on how we address issues like racism and reduce our carbon footprint, ensuring our actions align with the highest ethical standards.

Learn more

What we do

Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion.

View all topics Activities by country
Featured Gaza Israel war Conflict in Sudan Surgery & trauma care

Where we work

In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.

View all countries
Featured Palestine Sudan South Sudan

MSF Websites

A Global Network
Our offices around the world
Our offices around the world
Other Sites
View Resource Centre
Access Campaign

We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

GO TO SITE
CRASH

Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

GO TO SITE
UREPH

Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

GO TO SITE
ARHP

Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

GO TO SITE
MSF Analysis

Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

GO TO SITE
MSF Supply

This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
MSF Logistique

This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
Amsterdam Procurement Unit

This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

GO TO SITE
Brazilian Medical Unit

BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

GO TO SITE
MSF Medical Guidelines

Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

GO TO SITE
Epicentre

Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

GO TO SITE
Evaluation Units

Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

GO TO SITE
LGBTQI+ Inclusion in Health Settings

MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.

GO TO SITE
LUXOR

The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

GO TO SITE
MSF Academy for Healthcare

To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

GO TO SITE
Humanitarian Law

This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

GO TO SITE
MSF Paediatric Days

The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

GO TO SITE
MSF Foundation

The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

GO TO SITE
DNDi

A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

GO TO SITE
MSF Science Portal

Our digital portal dedicated to sharing the latest medical evidence from our humanitarian activities around the globe.

GO TO SITE
Noma

Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.

GO TO SITE
TIC

The TIC is aiming to change how MSF works to better meet the evolving needs of our patients.

GO TO SITE
Telemedicine

MSF's telemedicine hub aims to overcome geographic barriers for equitable, accessible, and quality patient care.

GO TO SITE
Sweden Innovation Unit

Launched in 2012, the MSF Sweden Innovation Unit deploys a human-centered approach for promoting a culture of innovation within MSF.

GO TO SITE
611 Results
 
Pneumonia vaccine signs
Access to medicines

Gavi must ensure more children get new, more affordable pneumonia vaccine

As vaccine funder Gavi, the Vaccine Alliance, celebrates its 20th anniversary, MSF is using the occasion to call out the organisation to ensure more children are protected against deadly pneumonia with a new, more affordable, vaccine. Press Release - 21 Jan 2020
 
NAURU - MSF forced to end its Mental Health activities
Nauru

Medevac repeal entrenches dangerous precedents on denial of medical care

The decision to repeal Australia’s ‘Medevac’ legislation - put in place in response to the need to medically evacuate people from detention on Nauru - endangers patients in need and ignores the ethical framework of the entire medical profession. msf.org.au - 4 Dec 2019
 
MSF stunt at Gavi replenishment meeting Berlin
Access to medicines

Pharma giants shouldn’t receive multi-million dollar pneumonia vaccine subsidy

After raking in billions of dollars on their pneumonia vaccines, pharma giants GSK and Pfizer are still being paid a subsidy by Gavi, the Vaccine Alliance. MSF says it must now stop. Press Release - 3 Dec 2019
 
Malawi - Advanced HIV
HIV/AIDS

AIDS death toll stagnating due to lack of testing at community level

Hundreds of thousands of people still die from AIDS because countries are ill-equipped to detect and treat them, new MSF report "No time to lose" reveals. Press Release - 1 Dec 2019
 
Georgia: DR-TB patients find hope in new treatments
Pakistan

Innovative TB trial starts in Sindh province

MSF and Interactive Research and Development have announced the start of a clinical trial in Pakistan that aims to find better, shorter treatments against multidrug-resistant forms of tuberculosis. Press Release - 31 Oct 2019
 
2018 Union Conference - Johnson & Johnson (J&J) protest
Access to medicines

MSF protests at TB conference against drug corporations keeping lifesaving medicines from people

Newer medicines for drug-resistant tuberculosis are desperately needed, but barriers to access, including high prices, keep them out of reach for most people around the world. MSF activists stormed the stage at a TB conference to protest. Press Release - 30 Oct 2019
 
Johnson & Johnson demonstration - bedaquiline
Access to medicines

MSF demands Johnson & Johnson reduce price of lifesaving TB drug

Despite benefiting from contributions, including tax payer funds, to develop tuberculosis drug bedaquiline, Johnson and Johnson are making huge profits - while people die. We demand that J&J halve the price of bedaquiline. Press Release - 10 Oct 2019
 
Insein clinic, for treatment for HIV, TB, and Hepatitis C in Yangon. By Alessandro Penso, Feb 2018.
HIV/AIDS

Urgent boost and reality check needed for HIV and TB funding

An MSF report looking at the funding shortfall for HIV and TB and resulting affects on patients in nine countries highlights the dangers for a potential reversal in the HIV and TB response if donor countries don't increase funding. Press Release - 6 Oct 2019
 
Mental Health testimonies
Iraq

MSF warns of mental health crisis among Yazidis in Iraq

A mental health crisis, including multiple suicides, is occurring in Iraq among the Yazidi community in Sinjar. IS atrocities took place here in 2014. Press Release - 4 Oct 2019
 
Safe Abortion Colombia illustration
Colombia

Women and girls prevented from having a safe abortion

Colombia decriminalised abortion more than a decade ago but women and girls still encounter numerous barriers when seeking to terminate pregnancies. Press Release - 25 Sep 2019
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more